Buy or sell Genapsys stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Genapsys Stock

DNA Sequencing Technology

Founded

2010

Notable Investors

Oxford Finance Corporation

Headquarters

Redwood City CA, US

Total Funding

$249M

About Genapsys Stock

GenapSys is actively looking to partner with local health agencies and researchers to arm researchers with access to the insight afforded by sequencing. With its sequencing technology, the company aims to help support the control and limit the spread of current and future outbreaks. The device can run off of a standard power source and is small enough to fit in the back of a truck or be deployed at hospitals, airports, and public transportation hubs for quick results on virus samples.

Investors

Decheng Capital

Genapsys

Foresite Capital

Genapsys, DNAnexus

Oxford Finance Corporation

Genapsys

Plug and Play

Genapsys

Funding History

September 2012$5.5M
March 2013$8.5M
November 2013$37.5M
January 2018$32.5M
November 2019$90.0M
February 2020$75.0M

Management

Founder & Chief Executive Officer

Hesaam Esfandyarpour

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Genapsys or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo